Document Detail


Blood compatibility of polyamidoamine dendrimers and erythrocyte protection.
MedLine Citation:
PMID:  20499836     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Dendrimers are global macromolecules with promising biomedical application. In order to investigate their blood compatibility, different generations of polyamidoamine (PAMAM) dendrimers terminated with different types of surface functional groups were incubated with red blood cells (RBC) for time course of haemolysis assay and RBC morphology observation. Cationic PAMAM dendrimers demonstrated obvious generation, concentration and time dependent haemolysis while anionic and neutral PAMAM dendrimers were much less hemolytic. The surface amino groups and the polymeric structure of cationic PAMAM dendrimers played pivotal roles in haemolysis induction; meanwhile the basic pH of cationic PAMAM solutions was an inneglectable factor. Due to the presence of plasma proteins in abundance, whole blood was found tolerable to haemolysis induced by dendrimers, possibly through complex formation of plasma proteins with cationic PAMAM dendrimers. It was deduced that poly-carboxylic acids may have the similar effect as that of plasma proteins. So by means of pH adjustment to the physical 7.4, reduction of administration dose and the combined use of plasma protein (or other protective additives such as negatively charged molecules), the blood compatibility and even biocompatibility of cationic dendrimers may be enhanced to "safe" level.
Authors:
Mei-Hua Han; Jing Chen; Jian Wang; Shi-Lin Chen; Xiang-Tao Wang
Related Documents :
19965186 - Simulation of erythrocyte deformation in a high shear flow.
8703856 - Blood viscosity, coagulation, and activated protein c resistance in central retinal vei...
3426986 - Whole blood viscosity during normal pregnancy.
15591096 - Alginate plasma expander maintains perfusion and plasma viscosity during extreme hemodi...
8832596 - Liver blood flow in chronic hemodialysis patients.
2356936 - Iatrogenic anaemia? a survey of venesection in patients in the intensive therapy unit.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of biomedical nanotechnology     Volume:  6     ISSN:  1550-7033     ISO Abbreviation:  J Biomed Nanotechnol     Publication Date:  2010 Feb 
Date Detail:
Created Date:  2010-05-26     Completed Date:  2010-06-29     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101230869     Medline TA:  J Biomed Nanotechnol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  82-92     Citation Subset:  IM    
Affiliation:
Chinese Academy of Medical Sciences and Peking Union Medical College Institute of Medicinal Plant Development, Beijing 100094, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Biocompatible Materials / chemistry,  pharmacology*
Cations / chemistry,  pharmacology
Cell Line
Cell Shape / drug effects
Cell Survival / drug effects
Cells, Cultured
Dendrimers / chemistry,  pharmacology*
Erythrocytes / drug effects*,  metabolism
Hemolysis / drug effects
Humans
Inhibitory Concentration 50
Materials Testing
Microscopy
Chemical
Reg. No./Substance:
0/Biocompatible Materials; 0/Cations; 0/Dendrimers; 0/PAMAM Starburst

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Feasibility of using a two-wavelength photometer to estimate the concentration of circulating near-i...
Next Document:  Biochemical properties and biological function of a monofunctional microbial biotin protein ligase.